Empiric Vancomycin Use in Febrile Neutropenic Oncology Patients

Vancomycin is commonly added as empiric therapy for febrile neutropenia. A retrospective chart review was conducted at a large community teaching institution to evaluate vancomycin use in oncology patients. The results revealed that a majority of empiric vancomycin therapy was inappropriate, raising...

Descripción completa

Detalles Bibliográficos
Autores principales: Libuit, Jessica, Whitman, Andrew, Wolfe, Rebecca, Washington, Casey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324182/
https://www.ncbi.nlm.nih.gov/pubmed/25734080
http://dx.doi.org/10.1093/ofid/ofu006
Descripción
Sumario:Vancomycin is commonly added as empiric therapy for febrile neutropenia. A retrospective chart review was conducted at a large community teaching institution to evaluate vancomycin use in oncology patients. The results revealed that a majority of empiric vancomycin therapy was inappropriate, raising concern for antibiotic resistance and prompting opportunities for improvement.

Ejemplares similares